←
Scheinberg Lab115 posts
Scheinberg Lab avatar

Scheinberg Lab

@DASLab_MSKCC

Developing cutting-edge therapeutics for cancer treatment @sloan_kettering. Tweets are from lab members, not from Dr. Scheinberg, unless signed -DAS.

◷ Joined September 2019▧ 9 Photos and videos
Mamadou A. Bah avatar
⟳ Scheinberg Lab retweeted
Mamadou A. Bah@M_AlphaBah·21 Apr 2023

Congratulations to Dr. Bourne (@TheBourneImmuno) my younger big brother for an incredible thesis today! You’re truly an inspirational person in and out of the lab. A phenomenal scientist, dedicated DEI activist, and a monster of a cyclist! UPenn is incredibly lucky to have you!

Post attachment
Scheinberg Lab avatar
Scheinberg Lab@DASLab_MSKCC·6 Feb 2023

Congratulations to Megan Dacek (@deg_macek) and Keifer Kurtz (@KeiferKurtz) on their recent Blood submission "Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker". Years of hard work have led to this therapeutic advancement.

Scheinberg Lab avatar
Scheinberg Lab@DASLab_MSKCC·16 May 2022

Congratulations to Dr. Heather Jones on her successful thesis defense today!! She delivered an outstanding presentation. Be on the lookout for her upcoming study on TCR cross-reactivity.

Scheinberg Lab avatar
Scheinberg Lab@DASLab_MSKCC·17 Apr 2022

Congratulations to former fellow @MgKlatt on this groundbreaking publication! Using Mass Spec, we identify a novel target, NDC80, and target it with TCR mimic antibodies.

I am celebrating! My 11th paper from my postdoc-time at the amazing @DASLab_MSKCC Lab is now out @BloodJournal. I thank all fantastic collaborators for their support but especially @EurekaThera for their help and unlimited enthusiasm for TCRmimics. ashpublications.org/blood/ar… 1/2

View quoted post ↗
Thomas Gardner avatar
⟳ Scheinberg Lab retweeted
Thomas Gardner@TJJardinero·30 Dec 2021

Excited to share my work from @DASLab_MSKCC lab out today in @nchembio where we develop CAR-T cells that produce small molecule drugs at the tumor site. This is an exciting step forward in the utilization of engineered cells for drug delivery! nature.com/articles/s41589-0…

Dr. Christopher Bourne (he/him) avatar
⟳ Scheinberg Lab retweeted
Dr. Christopher Bourne (he/him)@TheBourneImmuno·30 Dec 2021

One critique of this platform that uses bacterial enzymes is that host immune responses will reject it. In my thesis work, I adapt this project in fully immunocompetent mouse models. We've had very promising efficacy results so far!

Dr. Christopher Bourne (he/him) avatar
⟳ Scheinberg Lab retweeted
Dr. Christopher Bourne (he/him)@TheBourneImmuno·30 Dec 2021

In our @DASLab_MSKCC paper we demonstrate that T cells can be engineered to release small molecule chemotherapies at the tumor site. We do this using bacterial enzymes. In the current paper, we use immunodeficient mouse models as a human proof of concept.

Dr. Christopher Bourne (he/him) avatar
⟳ Scheinberg Lab retweeted
Dr. Christopher Bourne (he/him)@TheBourneImmuno·30 Dec 2021

2.5 years of revision and over 5 years of collaborative work, CONGRATULATIONS to @TJJardinero , @DASLab_MSKCC and all others who contributed to this manuscript 🎉🎉🥳🥳. This novel platform will change adoptive T cell therapy. My thesis work will build on this. More info 👇🏾👇🏾👇🏾

Excited to share my work from @DASLab_MSKCC lab out today in @nchembio where we develop CAR-T cells that produce small molecule drugs at the tumor site. This is an exciting step forward in the utilization of engineered cells for drug delivery! nature.com/articles/s41589-0…

View quoted post ↗
Scheinberg Lab avatar
Scheinberg Lab@DASLab_MSKCC·30 Dec 2021

Congratulations @TJJardinero and our collaborators in the Tan lab for this awesome work! We show how adoptive T cell therapies like CAR T cells can be used to deliver small-molecule drugs to tumors. This is the first manuscript of many to come on this project.

Excited to share my work from @DASLab_MSKCC lab out today in @nchembio where we develop CAR-T cells that produce small molecule drugs at the tumor site. This is an exciting step forward in the utilization of engineered cells for drug delivery! nature.com/articles/s41589-0…

View quoted post ↗